WSA
ASPX

Wall Street Associates’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Wall Street Associates’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-326,332
Closed -$32.7M – 376
2015
Q1 		$32.7M Sell
326,332
-105,768
-24% -$7.05M 3.09% 1
2014
Q4 		$22.7M Sell
432,100
-2,900
-0.7% -$85.2K 2.17% 1
2014
Q3 		$11.2M Buy
435,000
+210,000
+93% +$4.47M 1.15% 12
2014
Q2 		$5.01M Hold
225,000
– – 0.43% 87
2014
Q1 		$6.92M Buy
+225,000
New +$6.05M 0.57% 66

Wall Street Associates's ASPX Position: Q2 2015 in Review

Wall Street Associates sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 326,332 shares — an estimated $32.7M sold.

Wall Street Associates first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $32.7M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Wall Street Associates reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Wall Street Associates sold 326,332 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $32.7M.
  • Wall Street Associates first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • Wall Street Associates's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $32.7M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Wall Street Associates's 13F filing for Q2 2015, filed 13 Aug 2015.